Products

Products

Yeast-derived Hepatitis B Vaccine
  • Yeast-derived Hepatitis B VaccineYeast-derived Hepatitis B Vaccine

Yeast-derived Hepatitis B Vaccine

Welcome to choose AIM Honesty Biopharmaceutical Co., Ltd. as your long-term supplier. Our independently developed RECVAX® Yeast-derived Hepatitis B Vaccine, along with several other types of vaccines, utilizes industry-leading advanced technology, offering outstanding and long-lasting immune protection.

AIM Honesty Biopharmaceutical Co., Ltd. is a leading manufacturer and supplier of yeast-derived Hepatitis B vaccines in China. Our products are ideal for individuals susceptible to Hepatitis B and provide effective and safe protection.

Product Composition

The yeast-derived Hepatitis B Vaccine is made by purifying the Hepatitis B virus surface antigen (HBsAg) expressed by recombinant Hansenula polymorpha yeast, and then adding aluminum hydroxide adjuvant. The product is an off-white suspension that may separate into layers upon standing but is easily dispersed after shaking.

Active ingredient: Hepatitis B virus surface antigen.

Excipients: Aluminum hydroxide, sodium chloride.

Which Groups of People Need to Be Vaccinated Against Hepatitis B?

Individuals susceptible to hepatitis B need to be vaccinated, especially newborns.  Children whose mothers are HBsAg and HBeAg positive have a higher priority for vaccination. In addition, healthcare workers and laboratory personnel who handle blood also need to be vaccinated.

It is important to note that the Yeast-derived Hepatitis B Vaccine is not suitable for everyone. We do not recommend vaccination for the following groups:

(1) Individuals with known allergies to any component of the vaccine (including excipients, formaldehyde, and yeast).

(2) Patients with acute illnesses, severe chronic diseases, acute exacerbations of chronic diseases, and fever.

(3) Pregnant women.

(4) Patients with uncontrolled epilepsy and other progressive neurological diseases.

Yeast-derived Hepatitis B Vaccine

Product Specification

Compared to other technical routes, RECVAX® were produced with a more rigorous pharmacopeia standard, which improve the quality and safety of the product.

Pharmacopoeia Item Endotoxin content Free formaldehyde Thiocyanate Residual amount of antibiotics Residual amount of bovine serum albumin
Hansenula polymorpha Less than 5 EU/ml Less than 15 µg/ml Not applicable Not applicable Not applicable
Saccharomyces cerevisiae Less than 5 EU/ml Less than 20 µg/ml Should be less than 1 µg/ml Not applicable Not applicable
CHO cells Less than 10 EU/ml Less than 50 µg/ml Not applicable No more than 50 ng/dose No more than 50 ng/dose
Process Hansenula Yeast Saccharomyces Yeast CHO Cell
Process Description Most advanced process First generation yeast expression system Most dated process
Tumorigenic Risk? No No Yes
Antibiotic Added? No No Yes
Bovine Serum Albumin Added? No No Yes
Animal Pathogen Risk? No No Yes
Thiocyanate Added? No Yes No
Immunogenicity High Higher Not much (general double dose vs. yeast shows poor response)
Vaccine Purity Highest Higher More additives, lower purity
Potential Benefit Strongest cellular immunity induction Second strongest cellular immunity induction Weakest cellular immunity induction
Representative Product Statement 10 µg applicable to all populations 10 µg applicable only to children 10 µg immunogenicity poor, almost discontinued

Product Feature And Application

Yeast-derived Hepatitis B Vaccine: Each vial contains 0.5 ml, with a dose of 0.5 ml per person, containing 10 μg or 20 μg of HBsAg.

It is administered via intramuscular injection into the deltoid muscle of the upper arm.

The immunization schedule consists of three doses, administered at 0, 1, and 6 months. Newborns should receive the first dose within 24 hours of birth, with one dose administered at each vaccination.

The RECVAX® series of products has been on the market for 20 years, covering most provinces and cities in China, with a cumulative usage of nearly 500 million doses, demonstrating good booster immunization effects.

Yeast-derived Hepatitis B Vaccine

Production Details

Professional and modern production workshops are the cornerstone of high-quality products!

Yeast-derived Hepatitis B VaccineYeast-derived Hepatitis B VaccineYeast-derived Hepatitis B VaccineYeast-derived Hepatitis B Vaccine
Hot Tags: Yeast-derived Hepatitis B Vaccine, China, Manufacturer, Supplier, Factory
Send Inquiry
Contact Info
  • Address

    ● 26F, T6, Dazu Square, NO.2 Ronghua South Road, ETDZ, Beijing, China
    ● 10F, Port Building, 1 Fenghe Road, Pudong, Shanghai, China

For inquiries about human rabies vaccine, hepatitis B vaccine, hepatitis A vaccine or price list, please leave your email to us and we will be in touch within 24 hours.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept